Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex“) is pleased to announce that it has secured exclusive rights to sell and distribute COVID-19 saliva kit manufactured by WIZCHEM CO., LTD. (“WIZCHEM”) in Canada and Saudi Arabia, and non-exclusive rights for the United States of America, United Kingdom, and European Unions.
The Company signed the distribution agreement on January 28, 2021, to sell the COVICHEK™ Saliva DNA/RNA Collection Kit and COVICHEK™ Viral Transport Medium (together “COVICHEK™”) in Canada, United States, European Union, United Kingdom, and the Kingdom of Saud Arabia. The Company did not pay any consideration to the manufacturer to obtain sales rights.
COVICHEK™ Saliva Kit is a convenient DNA and RNA saliva collection device that stabilizes DNA and RNA long term in saliva sample. The saliva collection tube clearly indicates the volume of saliva required after which the funnel is removed, and cap replaced. The device is fully specified for sample transport and storage.
WIZCHEM has secured U.S. FDA EUA, CE mark certification, and is Good Manufacturing Practice (GMP) facilities compliant. These tests are manufactured the with permission from the Korean FDA based on ISO 13485, and sold globally. Each of the manufacturers’ medical devices will be submitted to Health Canada (“HC”) for approval on a fast track basis and, until such approval is granted, these tests may not be sold or used in Canada at this time.
Each of the manufacturers’ medical devices will be submitted to Saudi Food & Drug Authority (“SFDA”) for the Kingdom of Saudi Arabia for approval on a fast track basis.
“Datametrex has been awarded another incredible opportunity to secure an additional medical testing device supplier from South Korea with WIZCHEM. With the second wave of COVID-19 in the United States and throughout the world, we at Datametrex believes an increase in testing capacity is critical to test, track and protect populations,” said Marshall Gunter, CEO of Datametrex AI Limited.
Datametrex Secures Exclusive Rights to Distribute FDA, EUA and CE Approved COVID-19 Saliva Kit